• No results found

[PDF] Top 20 Development and Evaluation of Felodipine Extended Release Tablet Formulation

Has 10000 "Development and Evaluation of Felodipine Extended Release Tablet Formulation" found on our website. Below are the top 20 most common "Development and Evaluation of Felodipine Extended Release Tablet Formulation".

Development and Evaluation of Felodipine Extended Release Tablet Formulation

Development and Evaluation of Felodipine Extended Release Tablet Formulation

... Most drugs are weak acids or bases. Since the unchanged form of drug preferentially permeates across lipid membrane, the drug in an unchanged form is advantageous for drug permeation. Consider a drug for which the ... See full document

120

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF TAPENTADOL HCl

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF TAPENTADOL HCl

... “Formulation Development and Evaluation of Extended Release Tablets of Tapentadol ...the development of dosage form, all the fundamental physical and chemical properties of the ... See full document

11

FORMULATION AND DEVELOPMENT OF FLOATING DRUG DELIVERY SYSTEM OF METFORMIN HYDROCHLORIDE EXTENDED RELEASE AND GLIMEPIRIDE IMMEDIATE RELEASE INTO BILAYERED TABLET DOSAGE FORM: IN VITRO EVALUATION

FORMULATION AND DEVELOPMENT OF FLOATING DRUG DELIVERY SYSTEM OF METFORMIN HYDROCHLORIDE EXTENDED RELEASE AND GLIMEPIRIDE IMMEDIATE RELEASE INTO BILAYERED TABLET DOSAGE FORM: IN VITRO EVALUATION

... was formulation development and evaluation bi-layer floating tablets for metformin hydrochloride and glimepiride to improve the oral therapeutic efficacy Both these drugs exhibit pH dependent ... See full document

11

FORMULATION DEVELOPMENT AND EVALUATION OF TAPENTADOL HYDROCHLORIDE EXTENDED RELEASE MATRIX TABLETS

FORMULATION DEVELOPMENT AND EVALUATION OF TAPENTADOL HYDROCHLORIDE EXTENDED RELEASE MATRIX TABLETS

... material with lactose, starch, magnesium stearate and aerosil. Matrix tablets were evaluated by different parameters such as thickness, hardness, weight uniformity, content uniformity, in vitro drug release, in ... See full document

20

FORMULATION DEVELOPMENT AND EVALUATION OF METOPROLOL SUCCINATE SUSTAINED RELEASE AND HYDROCHLOROTHIAZIDE IMMEDIATE RELEASE BILAYER TABLET

FORMULATION DEVELOPMENT AND EVALUATION OF METOPROLOL SUCCINATE SUSTAINED RELEASE AND HYDROCHLOROTHIAZIDE IMMEDIATE RELEASE BILAYER TABLET

... Bilayer tablet punching machine consists of two hoppers and two feed frames separately without intermixing first and second layer of granules, as shown in ... See full document

8

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF EXTENDED RELEASE MEBEVERINE HCL PELLETS

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF EXTENDED RELEASE MEBEVERINE HCL PELLETS

... Stability studies: The drug and excipient compatibility study was done at accelerated conditions for short period of time (40 ± 2 ˚C / 75 ± 5 % RH) and long-term conditions (25 ± 2 ˚C /60 ± 5% RH) with periodic ... See full document

14

Formulation Development and In-Vitro Evaluation of
Potassium Chloride Extended Release Tablets

Formulation Development and In-Vitro Evaluation of Potassium Chloride Extended Release Tablets

... drug release from the dosage form. After making a good tablet, one must often coat ...the tablet surfaces become covered with a tacky polymeric ...the tablet surface dries, the applied coating ... See full document

90

FORMULATION DEVELOPMENT AND EVALUATION OF POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS

FORMULATION DEVELOPMENT AND EVALUATION OF POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS

... Tablet was introduced into dissolution fluid after it gets 37±5ºC temperature and the paddle was set at 50RPM motion. 9ml of test sample was withdrawn after 1hr, 2hr and later on 2hr interval, with syringe fitted ... See full document

13

Formulation development and evaluation of metoprolol succinate sustained release and hydrochlorothiazide immediate release bilayer tablet

Formulation development and evaluation of metoprolol succinate sustained release and hydrochlorothiazide immediate release bilayer tablet

... the development of new techniques for drug delivery ...drug release, extending the duration of therapeutic activity and targeting of drug to the needed area ...designed extended release dosage ... See full document

9

Formulation Design Development and Evaluation of Extended Release Matrix Tablets of Trimetazidine Hydrochloride.

Formulation Design Development and Evaluation of Extended Release Matrix Tablets of Trimetazidine Hydrochloride.

... One important factor for oral dosage forms is the loss of drug through acid hydrolysis and/or metabolism in the GI tract. Since a drug in the solid state undergoes degradation a much slower rate than a drug in ... See full document

109

 FORMULATION DEVELOPMENT AND EVALUATION OF CARVEDILOL TABLET

 FORMULATION DEVELOPMENT AND EVALUATION OF CARVEDILOL TABLET

... core tablet and coated tablet of all batches was acceptable (Figure ...3). Formulation B03, B08 and B09 showed higher disintegration time (Figure ...Drug release at 60 th minute was ... See full document

5

FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION OF IMMEDIATE RELEASE TABLET OF SITAGLIPTIN PHOSPHATE MONOHYDRATE

FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION OF IMMEDIATE RELEASE TABLET OF SITAGLIPTIN PHOSPHATE MONOHYDRATE

... glucagon release from alpha cells and slow the absorption of nutrients into blood stream and further causes an increase in the amount of insulin release from beta ... See full document

13

FORMULATION, DEVELOPMENT AND EVALUATION OF CARBAMAZEPINE EXTENDED RELEASE TABLET: DISSOLUTION APPARATUS USP IV

FORMULATION, DEVELOPMENT AND EVALUATION OF CARBAMAZEPINE EXTENDED RELEASE TABLET: DISSOLUTION APPARATUS USP IV

... prolonged release drug action ...Control release dosage form maximizing bioavaibility [5-6] of drug at site of action and minimize dose related side effect and maintaining relatively constant drug level for ... See full document

21

CONTROLLED RELEASE FORMULATION DEVELOPMENT AND EVALUATION OF FELODIPINE MATRIX TABLETS BY USING HYDROPHOBIC POLYMERS

CONTROLLED RELEASE FORMULATION DEVELOPMENT AND EVALUATION OF FELODIPINE MATRIX TABLETS BY USING HYDROPHOBIC POLYMERS

... the development of CR formulations, in addition to the relationship between the rates of drug release from the delivery system to the maximum achievable rate of drug absorption in to the systemic ... See full document

6

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF PULSATILE RELEASE TABLET OF BUDESONIDE

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF PULSATILE RELEASE TABLET OF BUDESONIDE

... www.wjpr.net Vol 4, Issue 1, 2015. 1199 Budesonide were selected as model standard drugs to treat IBD. Budesonide is a potent, synthetic non-halogenated corticosteroid with high topical anti-inflammatory effect and ... See full document

12

FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLET OF VALSARTAN

FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLET OF VALSARTAN

... manufacture. Tablet provides high precision ...immediate release dosage form is now a days popular oral dosage ...in development is the use of superdisintegrants which provide rapid disintegration of ... See full document

8

Formulation and evaluation of sustained release matrix tablet of captopril

Formulation and evaluation of sustained release matrix tablet of captopril

... benefits. Development of a captopril oral formulation would be a significant advantage for patient compliance accompanied by minimization of the drug side effects as a result of reduction in the drug blood ... See full document

9

Formulation and Evaluation of Extended Release Floating Matrix Tablet of Eperisone Hydrochloride by Direct Compression Method

Formulation and Evaluation of Extended Release Floating Matrix Tablet of Eperisone Hydrochloride by Direct Compression Method

... the development of sustained release (SR) or controlled release (CR) drug delivery ...systems extended release or controlled release rate can ach ieve predictable and ... See full document

7

Formulation and Evaluation of Extended Release Minitablets of Risperidone.

Formulation and Evaluation of Extended Release Minitablets of Risperidone.

... the development and the in vitro evaluation of sustained- release minitablets (MT), prepared by melt granulation and subsequent compression which are designed to float over an extended period ... See full document

72

Formulation and Evaluation of Extended/Immediate Release Bilayered Tablet

Formulation and Evaluation of Extended/Immediate Release Bilayered Tablet

... modified tablet presses are used to develop and produce such ...Multilayer tablet are bilayer, trilayer and four layer ...bilayer tablet is the new era for the successful development of ... See full document

8

Show all 10000 documents...

Related subjects